Endoscopic sleeve gastroplasty is an effective and safe minimally invasive approach for treatment of obesity: First Indian experience
Background and Aim Endoscopic sleeve gastroplasty (ESG) is gaining acceptance as a non‐surgical option for the treatment of obesity. However, its role is still not consolidated for all populations and the ideal indications are yet to be determined. We aimed to study the efficacy and safety of ESG in...
Gespeichert in:
| Veröffentlicht in: | Digestive endoscopy 2020-05, Vol.32 (4), p.541-546 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 546 |
|---|---|
| container_issue | 4 |
| container_start_page | 541 |
| container_title | Digestive endoscopy |
| container_volume | 32 |
| creator | Bhandari, Mohit Jain, Saransh Mathur, Winni Kosta, Susmit Neto, Manoel Galvao Brunaldi, Vitor Ottoboni Fobi, Mathias |
| description | Background and Aim
Endoscopic sleeve gastroplasty (ESG) is gaining acceptance as a non‐surgical option for the treatment of obesity. However, its role is still not consolidated for all populations and the ideal indications are yet to be determined. We aimed to study the efficacy and safety of ESG in Indian patients.
Methods
We conducted a single‐center retrospective study of obese patients who underwent consecutive ESG at our tertiary care center. Data on weight loss and adverse events at 1, 3, 6, and 12 months were collected and analyzed.
Results
Fifty‐three patients underwent ESG from March 2017 to October 2018. Eighty one percent of patients were female (43/53). Mean baseline age and body mass index were 40.54 ± 13.79 years and 34.78 ± 5.20 kg/m2, respectively. Mean duration of procedure was 68.96 ± 11.19 min. Immediate postoperative complications included mainly epigastric pain (45.2%) and nausea (22.6%) but there was no serious adverse event. Average percentage of total weight loss (%TWL) was 8.26%, 11.96%, 14.25%, and 19.94% at 1, 3, 6, and 12 months, respectively. Eighty‐eight percent of patients achieved >15% TWL at 12 months. Younger patients ( |
| doi_str_mv | 10.1111/den.13508 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2270004404</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2270004404</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3498-bbb79eb465e5af87847d5aea24f3eda7e89d566170360e5bd4b6fdc53f5e31f53</originalsourceid><addsrcrecordid>eNp1kLtOxDAQRS0EgmWh4AeQSygC9trOgw4ty0NaQQN15NhjMErsYGeBfAD_jWGBjmluMUdHMxehA0pOaJpTDe6EMkHKDTShnLOM5jndRBNSUZGJnIkdtBvjMyF0VnG-jXYYZRUnJJ-gj4XTPirfW4VjC_AK-FHGIfi-TTFiG7F0GIwBNdi0lE7jKA3gzjrbybZNiHuV8XvX98FL9YSND3gIIIcO3IC9wb6BaIfxDF_aEAd847T9sr73ECw4BXtoy8g2wv5PTtHD5eJ-fp0t765u5ufLTDFelVnTNEUFDc8FCGnKouSFFhLkjBsGWhZQVlqk1wvCcgKi0bzJjVaCGQGMGsGm6GjtTYe-rCAOdWejgraVDvwq1rNZQQjhnPCEHq9RFXyMAUzdh_RwGGtK6q_W69R6_d16Yg9_tKumA_1H_tacgNM18GZbGP831ReL27XyE-akjts</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2270004404</pqid></control><display><type>article</type><title>Endoscopic sleeve gastroplasty is an effective and safe minimally invasive approach for treatment of obesity: First Indian experience</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Bhandari, Mohit ; Jain, Saransh ; Mathur, Winni ; Kosta, Susmit ; Neto, Manoel Galvao ; Brunaldi, Vitor Ottoboni ; Fobi, Mathias</creator><creatorcontrib>Bhandari, Mohit ; Jain, Saransh ; Mathur, Winni ; Kosta, Susmit ; Neto, Manoel Galvao ; Brunaldi, Vitor Ottoboni ; Fobi, Mathias</creatorcontrib><description>Background and Aim
Endoscopic sleeve gastroplasty (ESG) is gaining acceptance as a non‐surgical option for the treatment of obesity. However, its role is still not consolidated for all populations and the ideal indications are yet to be determined. We aimed to study the efficacy and safety of ESG in Indian patients.
Methods
We conducted a single‐center retrospective study of obese patients who underwent consecutive ESG at our tertiary care center. Data on weight loss and adverse events at 1, 3, 6, and 12 months were collected and analyzed.
Results
Fifty‐three patients underwent ESG from March 2017 to October 2018. Eighty one percent of patients were female (43/53). Mean baseline age and body mass index were 40.54 ± 13.79 years and 34.78 ± 5.20 kg/m2, respectively. Mean duration of procedure was 68.96 ± 11.19 min. Immediate postoperative complications included mainly epigastric pain (45.2%) and nausea (22.6%) but there was no serious adverse event. Average percentage of total weight loss (%TWL) was 8.26%, 11.96%, 14.25%, and 19.94% at 1, 3, 6, and 12 months, respectively. Eighty‐eight percent of patients achieved >15% TWL at 12 months. Younger patients (<30 years old) and female patients had greater %TWL at 12 months (P = 0.01 and P = 0.021, respectively). Last 18 procedures were significantly faster than the first 35 cases (P = 0.01).
Conclusions
Endoscopic sleeve gastroplasty is effective and safe at promoting weight loss in the Indian population. Young age and female gender are related to better outcomes.</description><identifier>ISSN: 0915-5635</identifier><identifier>EISSN: 1443-1661</identifier><identifier>DOI: 10.1111/den.13508</identifier><identifier>PMID: 31394006</identifier><language>eng</language><publisher>Australia</publisher><subject>Adult ; bariatric ; Body Mass Index ; endoscopic sleeve gastroplasty ; Endoscopy ; Female ; Follow-Up Studies ; Gastroplasty ; Humans ; India ; Male ; Middle Aged ; obesity ; Obesity - surgery ; Treatment Outcome ; Weight Loss</subject><ispartof>Digestive endoscopy, 2020-05, Vol.32 (4), p.541-546</ispartof><rights>2019 Japan Gastroenterological Endoscopy Society</rights><rights>2019 Japan Gastroenterological Endoscopy Society.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3498-bbb79eb465e5af87847d5aea24f3eda7e89d566170360e5bd4b6fdc53f5e31f53</citedby><cites>FETCH-LOGICAL-c3498-bbb79eb465e5af87847d5aea24f3eda7e89d566170360e5bd4b6fdc53f5e31f53</cites><orcidid>0000-0003-3315-8640</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fden.13508$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fden.13508$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31394006$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bhandari, Mohit</creatorcontrib><creatorcontrib>Jain, Saransh</creatorcontrib><creatorcontrib>Mathur, Winni</creatorcontrib><creatorcontrib>Kosta, Susmit</creatorcontrib><creatorcontrib>Neto, Manoel Galvao</creatorcontrib><creatorcontrib>Brunaldi, Vitor Ottoboni</creatorcontrib><creatorcontrib>Fobi, Mathias</creatorcontrib><title>Endoscopic sleeve gastroplasty is an effective and safe minimally invasive approach for treatment of obesity: First Indian experience</title><title>Digestive endoscopy</title><addtitle>Dig Endosc</addtitle><description>Background and Aim
Endoscopic sleeve gastroplasty (ESG) is gaining acceptance as a non‐surgical option for the treatment of obesity. However, its role is still not consolidated for all populations and the ideal indications are yet to be determined. We aimed to study the efficacy and safety of ESG in Indian patients.
Methods
We conducted a single‐center retrospective study of obese patients who underwent consecutive ESG at our tertiary care center. Data on weight loss and adverse events at 1, 3, 6, and 12 months were collected and analyzed.
Results
Fifty‐three patients underwent ESG from March 2017 to October 2018. Eighty one percent of patients were female (43/53). Mean baseline age and body mass index were 40.54 ± 13.79 years and 34.78 ± 5.20 kg/m2, respectively. Mean duration of procedure was 68.96 ± 11.19 min. Immediate postoperative complications included mainly epigastric pain (45.2%) and nausea (22.6%) but there was no serious adverse event. Average percentage of total weight loss (%TWL) was 8.26%, 11.96%, 14.25%, and 19.94% at 1, 3, 6, and 12 months, respectively. Eighty‐eight percent of patients achieved >15% TWL at 12 months. Younger patients (<30 years old) and female patients had greater %TWL at 12 months (P = 0.01 and P = 0.021, respectively). Last 18 procedures were significantly faster than the first 35 cases (P = 0.01).
Conclusions
Endoscopic sleeve gastroplasty is effective and safe at promoting weight loss in the Indian population. Young age and female gender are related to better outcomes.</description><subject>Adult</subject><subject>bariatric</subject><subject>Body Mass Index</subject><subject>endoscopic sleeve gastroplasty</subject><subject>Endoscopy</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Gastroplasty</subject><subject>Humans</subject><subject>India</subject><subject>Male</subject><subject>Middle Aged</subject><subject>obesity</subject><subject>Obesity - surgery</subject><subject>Treatment Outcome</subject><subject>Weight Loss</subject><issn>0915-5635</issn><issn>1443-1661</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kLtOxDAQRS0EgmWh4AeQSygC9trOgw4ty0NaQQN15NhjMErsYGeBfAD_jWGBjmluMUdHMxehA0pOaJpTDe6EMkHKDTShnLOM5jndRBNSUZGJnIkdtBvjMyF0VnG-jXYYZRUnJJ-gj4XTPirfW4VjC_AK-FHGIfi-TTFiG7F0GIwBNdi0lE7jKA3gzjrbybZNiHuV8XvX98FL9YSND3gIIIcO3IC9wb6BaIfxDF_aEAd847T9sr73ECw4BXtoy8g2wv5PTtHD5eJ-fp0t765u5ufLTDFelVnTNEUFDc8FCGnKouSFFhLkjBsGWhZQVlqk1wvCcgKi0bzJjVaCGQGMGsGm6GjtTYe-rCAOdWejgraVDvwq1rNZQQjhnPCEHq9RFXyMAUzdh_RwGGtK6q_W69R6_d16Yg9_tKumA_1H_tacgNM18GZbGP831ReL27XyE-akjts</recordid><startdate>202005</startdate><enddate>202005</enddate><creator>Bhandari, Mohit</creator><creator>Jain, Saransh</creator><creator>Mathur, Winni</creator><creator>Kosta, Susmit</creator><creator>Neto, Manoel Galvao</creator><creator>Brunaldi, Vitor Ottoboni</creator><creator>Fobi, Mathias</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3315-8640</orcidid></search><sort><creationdate>202005</creationdate><title>Endoscopic sleeve gastroplasty is an effective and safe minimally invasive approach for treatment of obesity: First Indian experience</title><author>Bhandari, Mohit ; Jain, Saransh ; Mathur, Winni ; Kosta, Susmit ; Neto, Manoel Galvao ; Brunaldi, Vitor Ottoboni ; Fobi, Mathias</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3498-bbb79eb465e5af87847d5aea24f3eda7e89d566170360e5bd4b6fdc53f5e31f53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult</topic><topic>bariatric</topic><topic>Body Mass Index</topic><topic>endoscopic sleeve gastroplasty</topic><topic>Endoscopy</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Gastroplasty</topic><topic>Humans</topic><topic>India</topic><topic>Male</topic><topic>Middle Aged</topic><topic>obesity</topic><topic>Obesity - surgery</topic><topic>Treatment Outcome</topic><topic>Weight Loss</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bhandari, Mohit</creatorcontrib><creatorcontrib>Jain, Saransh</creatorcontrib><creatorcontrib>Mathur, Winni</creatorcontrib><creatorcontrib>Kosta, Susmit</creatorcontrib><creatorcontrib>Neto, Manoel Galvao</creatorcontrib><creatorcontrib>Brunaldi, Vitor Ottoboni</creatorcontrib><creatorcontrib>Fobi, Mathias</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Digestive endoscopy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bhandari, Mohit</au><au>Jain, Saransh</au><au>Mathur, Winni</au><au>Kosta, Susmit</au><au>Neto, Manoel Galvao</au><au>Brunaldi, Vitor Ottoboni</au><au>Fobi, Mathias</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Endoscopic sleeve gastroplasty is an effective and safe minimally invasive approach for treatment of obesity: First Indian experience</atitle><jtitle>Digestive endoscopy</jtitle><addtitle>Dig Endosc</addtitle><date>2020-05</date><risdate>2020</risdate><volume>32</volume><issue>4</issue><spage>541</spage><epage>546</epage><pages>541-546</pages><issn>0915-5635</issn><eissn>1443-1661</eissn><abstract>Background and Aim
Endoscopic sleeve gastroplasty (ESG) is gaining acceptance as a non‐surgical option for the treatment of obesity. However, its role is still not consolidated for all populations and the ideal indications are yet to be determined. We aimed to study the efficacy and safety of ESG in Indian patients.
Methods
We conducted a single‐center retrospective study of obese patients who underwent consecutive ESG at our tertiary care center. Data on weight loss and adverse events at 1, 3, 6, and 12 months were collected and analyzed.
Results
Fifty‐three patients underwent ESG from March 2017 to October 2018. Eighty one percent of patients were female (43/53). Mean baseline age and body mass index were 40.54 ± 13.79 years and 34.78 ± 5.20 kg/m2, respectively. Mean duration of procedure was 68.96 ± 11.19 min. Immediate postoperative complications included mainly epigastric pain (45.2%) and nausea (22.6%) but there was no serious adverse event. Average percentage of total weight loss (%TWL) was 8.26%, 11.96%, 14.25%, and 19.94% at 1, 3, 6, and 12 months, respectively. Eighty‐eight percent of patients achieved >15% TWL at 12 months. Younger patients (<30 years old) and female patients had greater %TWL at 12 months (P = 0.01 and P = 0.021, respectively). Last 18 procedures were significantly faster than the first 35 cases (P = 0.01).
Conclusions
Endoscopic sleeve gastroplasty is effective and safe at promoting weight loss in the Indian population. Young age and female gender are related to better outcomes.</abstract><cop>Australia</cop><pmid>31394006</pmid><doi>10.1111/den.13508</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0003-3315-8640</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0915-5635 |
| ispartof | Digestive endoscopy, 2020-05, Vol.32 (4), p.541-546 |
| issn | 0915-5635 1443-1661 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2270004404 |
| source | MEDLINE; Access via Wiley Online Library |
| subjects | Adult bariatric Body Mass Index endoscopic sleeve gastroplasty Endoscopy Female Follow-Up Studies Gastroplasty Humans India Male Middle Aged obesity Obesity - surgery Treatment Outcome Weight Loss |
| title | Endoscopic sleeve gastroplasty is an effective and safe minimally invasive approach for treatment of obesity: First Indian experience |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T17%3A36%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Endoscopic%20sleeve%20gastroplasty%20is%20an%20effective%20and%20safe%20minimally%20invasive%20approach%20for%20treatment%20of%20obesity:%20First%20Indian%20experience&rft.jtitle=Digestive%20endoscopy&rft.au=Bhandari,%20Mohit&rft.date=2020-05&rft.volume=32&rft.issue=4&rft.spage=541&rft.epage=546&rft.pages=541-546&rft.issn=0915-5635&rft.eissn=1443-1661&rft_id=info:doi/10.1111/den.13508&rft_dat=%3Cproquest_cross%3E2270004404%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2270004404&rft_id=info:pmid/31394006&rfr_iscdi=true |